Background illustration for clinical trials search

Paid Clinical Trials San Jose

Discover 2,242 paid clinical trials in San Jose, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System

for
Heart Failure, Cardiogenic Shock, Congenital Heart Disease,
Location: Palo Alto CA, Seattle WA, Dallas TX, Durham NC,
Sponsor: Stanford University

Sex: All

Age: 0 - 16

Code: NCT06080074

Phase 2, Recruiting

Stanford Pediatric Healthy Weight Index

for
Obesity & Overweight
Location: Palo Alto CA
Sponsor: Stanford University

Sex: All

Age: 10 - 18

Code: NCT07316816

Recruiting

Integrating Systems and Basic Income: Improving Outcomes for Families of Young Children

for
Income, Infant, Newborn, Mothers, Poverty, United States,
Location: Palo Alto CA
Sponsor: Stanford University

Sex: All

Age: 0+

Code: NCT07261254

Recruiting

Supraglottic Airway for Resuscitation Trial

for
Neonatal Resuscitation, Delivery Room Resuscitation,
Location: Palo Alto CA, Dallas TX, Rochester MN, Little Rock AR,
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 0+

Code: NCT07150923

Recruiting

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

for
Recurrent Solid Tumor, Recurrent Ewing Sarcoma,
Location: Palo Alto CA, Aurora CO, Minneapolis MN, Memphis TN,
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 1 - 30

Code: NCT04901702

Phase 1, Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Beeline: A Phase 3 Study in GRIN-related Neurodevelopmental Disorder

for
GRIN-related Neurodevelopmental Disorder
Location: Palo Alto CA, Los Angeles CA, Seattle WA, Aurora CO,
Sponsor: GRIN Therapeutics, Inc.

Sex: All

Age: 0 - 18

Code: NCT07224581

Phase 3, Recruiting

Non-invasive Prediction of EArly Cardiac rEjection

for
Heart Transplant, Pediatric Heart Transplant, Rejection,
Location: Palo Alto CA, Los Angeles CA, San Diego CA, Seattle WA,
Sponsor: Vanderbilt University Medical Center

Sex: All

Age: 6 - 25

Code: NCT07770659

Recruiting

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

for
Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular,
Location: Palo Alto CA, Oakland CA, San Francisco CA,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 30

Code: NCT03126916

Phase 3, Recruiting

A Feasibility Study to Evaluate Safety and Probable Benefit of the Eclipse XL1 System for Distraction Enterogenesis in Adult and Pediatric Patients With Short Bowel Syndrome

for
Short Bowel Syndrome
Location: Palo Alto CA, San Francisco CA, Cincinnati OH,
Sponsor: Eclipse Regenesis, Inc.

Sex: All

Age: 0 - 65

Code: NCT05535361

Recruiting

Optimal Ventilation for Cardiac Arrest

for
Cardiac Arrest (CA)
Location: Palo Alto CA, Orange CA, Seattle WA, Denver CO,
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 0 - 18

Code: NCT07114510

Recruiting

A Long-Term Safety Follow-up Registry for Patients Who Received Treatment With Prademagene Zamikeracel for Recessive Dystrophic Epidermolysis Bullosa (RDEB) in the Post-Marketing Setting

for
Recessive Dystrophic Epidermolysis Bullosa
Location: Palo Alto CA, Aurora CO, Galveston TX, Chicago IL
Sponsor: Abeona Therapeutics, Inc

Sex: All

Age: 0+

Code: NCT07700966

Recruiting

Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor

for
Desmoplastic Small Round Cell Tumor, Osteosarcoma,
Location: Palo Alto CA, Los Angeles CA, Portland OR, Seattle WA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 12 - 39

Code: NCT04616560

Phase 2, Recruiting

A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)

for
Acute Myeloid Leukemia
Location: Palo Alto CA, Dallas TX, Nashville TN, Atlanta GA,
Sponsor: AbbVie

Sex: All

Age: 0 - 17

Code: NCT07306832

Phase 1, Recruiting

GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults

for
Medulloblastoma, Central Nervous System Embryonal Tumor,
Location: Palo Alto CA
Sponsor: Stanford University

Sex: All

Age: 1 - 30

Code: NCT07087002

Phase 1, Recruiting

Assessing the Safety, Tolerability, and Efficacy of APR-2020 in Pediatric and Adolescent Subjects With RPS19 Deficient Diamond-Blackfan Anemia

for
RPS19 Deficient Diamond-Blackfan Anemia
Location: Stanford CA, Boston MA
Sponsor: Apriligen, Inc.

Sex: All

Age: 2 - 25

Code: NCT07476183

Phase 1, Recruiting

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

for
Coronavirus Infection (COVID-19),
Location: Palo Alto CA, Austin TX, Cincinnati OH, Durham NC,
Sponsor: Duke University

Sex: All

Age: 0 - 20

Code: NCT04278404

Recruiting

iMOVE: Virtual Reality PT Versus Traditional PT

for
Physical Health
Location: Palo Alto CA
Sponsor: Stanford University

Sex: All

Age: 10 - 25

Code: NCT05876156

Recruiting

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

for
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
Location: Palo Alto CA, Oakland CA, San Francisco CA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 30

Code: NCT04546399

Phase 2, Recruiting

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

for
B Acute Lymphoblastic Leukemia
Location: Palo Alto CA, Oakland CA, San Francisco CA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 46

Code: NCT06124157

Phase 2, Recruiting

A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis

for
Recurrent Langerhans Cell Histiocytosis,
Location: Palo Alto CA, Oakland CA, San Francisco CA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 22

Code: NCT05828069

Phase 2, Recruiting